Severe Hypokalemic Paralysis Following Rituximab Infusion in a Patient With Microscopic Polyangitis
Year: 2025
Type: article
Study design: Case Report
Abstract: Rituximab is an anti-CD20 monoclonal antibody that has become an increasingly popular choice for the treatment of various autoimmune diseases. Various adverse effects have been attributed to the use of rituximab. Hypokalemia is one rare adverse reaction that is under reported in the literature and is life threatening. Here we report the case of a patient with symptomatic hypokalemia after IV rituximab infusion. Acute hypokalemia should be taken into account by healthcare professionals as a possible side effect after rituximab infusion.
Source: Cureus
DOI: 10.7759/cureus.84750
Authors: Yousuf Sherwani, Ayham Alsaab, Mohan Sengodan
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4410714013